Sheng Zhong
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 5
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 11
- RNA modifications and cancer 8
- Cancer-related gene regulation 6
- Genetics top 10%
- Glioma Diagnosis and Treatment 12
- Oncology top 10%
- Animal Science and Zoology top 5%
-
- Brain Metastases and Treatment 4
-
- Advanced Image Fusion Techniques 4
-
- Pituitary Gland Disorders and Treatments 3
- Co-authors
- Keith D. RobertsonC. Robert FieldsRaouf A. KhalilWing H. WongGregory DavidJaco van der TorreJan‐Hermen DannenbergRonald A. DePinho
- Journals
- Journal of the American Chemical Society (2 papers)Genes & Development (1 paper)Blood (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Sheng Zhong
77 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 133
- Cancer Research 349
- Molecular Biology 1.1k
- Genetics 114
- Oncology 279
- Animal Science and Zoology 92
Countries citing papers authored by Sheng Zhong
This map shows the geographic impact of Sheng Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Zhong more than expected).
Fields of papers citing papers by Sheng Zhong
This network shows the impact of papers produced by Sheng Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Zhong. The network helps show where Sheng Zhong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheng Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 14 | |
| 6 | 2024 | 17 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 67 | |
| 12 | 2023 | 15 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 17 | |
| 15 | 2020 | 3 | |
| 16 | 2019 | 24 | |
| 17 | 2017 | 16 | |
| 18 | 2008 | 18 | |
| 19 | 2006 | 141 | |
| 20 | 2006 | 154 |
About Sheng Zhong
Sheng Zhong is a scholar working on Genetics, Cancer Research and Oncology, having authored 85 papers that have together received 1.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), Epigenetics and DNA Methylation (11 papers), RNA modifications and cancer (8 papers), Cancer-related gene regulation (6 papers), Cancer-related molecular mechanisms research (5 papers), Brain Metastases and Treatment (4 papers), Advanced Image Fusion Techniques (4 papers) and Pituitary Gland Disorders and Treatments (3 papers). The work is most often cited by research in Cancer Research (349 citations), Molecular Biology (1.1k citations) and Genetics (114 citations). Sheng Zhong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Keith D. Robertson, C. Robert Fields, Raouf A. Khalil, Wing H. Wong, Gregory David, Jaco van der Torre, Jan‐Hermen Dannenberg, Ronald A. DePinho, Jeong Hoon Kim and Tae‐You Kim. Their work appears in journals such as Journal of the American Chemical Society, Genes & Development and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.